Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03664778 · ClinicalTrials.gov registry record

Abbreviated Breast MRI After Cancer Treatment

A clinical trial, sponsored by University of Pennsylvania.

Completed
Registry status
184
Enrollment target

NCT03664778: Completed study, sponsored by University of Pennsylvania.

NCT03664778 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 184 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03664778 has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
184 participants
Enrollment target

Study Summary

500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negative DBT examination six months prior to recruitment 3. all breast densities 4. clinically asymptomatic - no palpable masses, focalthickening, or clinically significant discharge We will identify these patients EPIC database utilizing the date of their last mammogram. The patients will be sent a letter explaining the study and the opportunity to enroll in the study. Interested patients may contact our research coordinators by the phone number provided in the letter. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2018-09-07
Est. Completion 2025-09-30

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03664778

The ClinicalTrials.gov registry entry for NCT03664778 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03664778 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03664778 about?

NCT03664778 is a clinical study titled "Abbreviated Breast MRI After Cancer Treatment". 500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negative DBT examination si...

What is the current status of trial NCT03664778?

This trial is currently completed. The enrollment target is 184 participants. The study started on 2018-09-07. Estimated completion is 2025-09-30.

Who is sponsoring clinical trial NCT03664778?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.